Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico
Autor: | Carlos A. Flores-López, Rafael Laniado-Laborín, Dulce Maria Juarez-Eusebio, Raquel Muñiz-Salazar, Roberto Zenteno-Cuevas, José Armando Martínez-Guarneros, Daniela Munro-Rojas |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Microbiology (medical) Genotype Extensively Drug-Resistant Tuberculosis 030106 microbiology Antitubercular Agents Drug resistance Microbial Sensitivity Tests Minisatellite Repeats Biology Microbiology Mycobacterium tuberculosis 03 medical and health sciences Bacterial Proteins Tuberculosis Multidrug-Resistant Genetics medicine Prevalence Cluster Analysis Humans Multidrug-Resistant Mycobacterium tuberculosis Molecular Biology Mexico Ecology Evolution Behavior and Systematics Extensively drug-resistant tuberculosis Genetic Variation rpoB medicine.disease biology.organism_classification Infectious Diseases Mutation Multilocus sequence typing Rifampicin medicine.drug Multilocus Sequence Typing |
Zdroj: | Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 55 |
ISSN: | 1567-7257 |
Popis: | Mexico is one of the most important contributors of multidrug resistance tuberculosis (MDR-TB) in Latin-America, however little is known about the molecular characteristics of these strains. For this reason, the objective of this work was to determine the genotype and characterize polymorphisms in genes associated with resistance to rifampicin, isoniazid, and second-line drugs in isolates from two regions of Mexico with high prevalence of drug resistant tuberculosis. Clinical isolates from individuals with confirmed MDR-TB were genotyped using MIRU-VNTR 12 loci. To characterize the polymorphisms in genes associated with resistance to rifampicin, isoniazid and second-line drugs; rpoB, katG, inhA, rrs, eis, gyrA, gyrB and tlyA were sequenced. 22 (41%) of the 54 MDR-TB isolates recovered were from the state of Baja California, while 32 (59%) were from Veracruz. The results show the katGS315T mutation was observed in 20% (11/54) of the isolates, while rpoBS315L was present in 33% (18/54). rrs had three polymorphisms (T1239C, ntA1401C and ntA1401G), gyrB presented no modifications, whereas gyrA showed five (S95T, F60Y, A90V, S91P and P124A), eis two (G-10A and A431G) and tlyA one (insertion at codon 67). Only 20% (11/54) of isolates were confirmed as MDR-TB by sequencing, and no mutations at any of the genes sequenced were observed in 43% (23/54) of the strains. Two isolates were recognized with the proper set of mutations like pre-XDR and one was XDR-TB. Eighteen isolates were classified as orphans and the remaining thirty-six were distributed in fourteen lineages, the most frequent were S (11%), Haarlem (9%), Ghana (9%) and LAM (7%). Out of the fourteen clusters identified, seven included unknown genotypes and nine had lineages. This is one of the most detailed analyses of genotypic characteristics and mutations associated with drug resistance to first and second-line drugs in MDR-TB isolates from Mexico. An important genetic variability and significant discrepancy between phenotypic tests and polymorphisms was observed. Our results set the need to screen additional loci as well as implement a molecular epidemiological surveillance system of MDR-TB in the country. |
Databáze: | OpenAIRE |
Externí odkaz: |